Treatment Research Program - Maryland Psychiatric Research Center - MPRC

Treatment Research Program - Maryland Psychiatric Research Center - MPRC The TRP has been dedicated to the study and treatment of people with schizophrenia since 1989.

05/06/2024

MPRC is walking!

Come check out MPRC's 2024 Art Exhibit and Auction on May 18!
04/16/2024

Come check out MPRC's 2024 Art Exhibit and Auction on May 18!

MPRC faculty attended the Schizophrenia International Research Society (SIRS) meeting this past weekDr Stephanie Kulaga ...
04/12/2024

MPRC faculty attended the Schizophrenia International Research Society (SIRS) meeting this past week

Dr Stephanie Kulaga presented data from a group of people with schizophrenia showing that long term inflammation is present after a COVID infection compared to those without prior infection. What will this mean long term?

Last night we celebrated the career and retirement of Dr William T Carpenter, Jr. As the founding director of the Maryla...
03/23/2024

Last night we celebrated the career and retirement of Dr William T Carpenter, Jr.

As the founding director of the Maryland Psychiatric Research Center, a compassionate psychiatrist, a dedicated mentor, and truly great icon in the field of psychiatry, over 150 people gathered on the grounds of Spring Grove Hospital Center in Catonsville, MD where it all began, to say our goodbyes.

Dr Carpenter helped establish the field standards in informed consent and ethical conduct of studies with people who have severe mental illness, reshaped the schizophrenia chapter in DSM-5, tested new treatments, was part of a Presidential envoy to the then Soviet Union, and served as the expert defense for Hinkley, helping the world understand what schizophrenia was.

Publishing over 400 peer reviewed papers, establishing the joint Treatment Research Unit with Spring Grove Hospital and Maryland Department of Health , opening a state of the art neuroimaging center, receiving some of the highest awards in science and medicine, serving many of the most prominent psychiatric organizations, growing the Schizophrenia Bulletin, and doing all of this after turning down a 1958 spot on the Baltimore Colts football team -highlight Dr Carpenter’s legendary life!

His humility, warm smile and generous nature will especially be missed. Congratulations to one of University of Maryland, Baltimore (UMB) most Distinguished Professors!!

Check out this great article on keto. It features our ongoing clinical trial!
01/28/2024

Check out this great article on keto. It features our ongoing clinical trial!

It's not just for weight loss. Patients and doctors alike are having success using the diet for illnesses like bipolar disorder and schizophrenia. And research is taking off.

12/16/2023

KarXT demonstrated statistically significant and clinically meaningful improvements in positive and negative symptoms of schizophrenia compared to placebo, as measured by primary and secondary endpoints KarXT was generally well tolerated and not associated with many adverse events typically

Happy holidays from the Treatment Research Program team!!
12/16/2023

Happy holidays from the Treatment Research Program team!!

Dr Deanna Kelly and her science is featured in the latest National Geographic article.   Women with   deserve personaliz...
12/09/2023

Dr Deanna Kelly and her science is featured in the latest National Geographic article. Women with deserve personalized care! https://t.co/iJO9aZG7HD

natgeo Meryl Davids

Not enough is known about how the disease affects women, who are more likely than men to be overlooked—and more likely to develop the disease in midlife.

10/28/2023

Dr Deanna Kelly and her colleagues have completed the first multinational clinical trial of clozapine in Black patients where they examined the safety and rates of neutropenia in a population with the ACKR1-null genotype. People with this genotype are at risk for low neutrophils. This study was conducted in Maryland, DC, and Lagos, Nigeria, and will help expand the use of the important antipsychotic worldwide.

https://www.sciencedirect.com/science/article/abs/pii/S0920996423002608?via%3Dihub

Today is the last day of Mental Health Awareness Month, but we continue to advocate for mental health and work to end th...
05/31/2023

Today is the last day of Mental Health Awareness Month, but we continue to advocate for mental health and work to end the stigma every day 💚

Although we focus on psychotic disorders, mental illness can take many different forms. Maintaining healthy habits can reduce the risk of developing a mental illness or provide a form of relief to existing mental illness.

I’ve arrived in DC!  Today I will be advocating for clozapine treatment barriers to be eliminated!    American Associati...
05/24/2023

I’ve arrived in DC! Today I will be advocating for clozapine treatment barriers to be eliminated!
American Association of Psychiatric Pharmacists - AAPP
Schizophrenia & Psychosis Action Alliance
NAMI Maryland
University of Maryland School of Medicine

Today is World Schizophrenia Day!We work to reduce stigma, spread awareness, and increase knowledge of the diagnosis thr...
05/24/2023

Today is World Schizophrenia Day!

We work to reduce stigma, spread awareness, and increase knowledge of the diagnosis through research every day. Individuals with schizophrenia, schizoaffective disorder, and other psychotic disorders deserve to be treated with humanity and given opportunities to receive mental health care.

We celebrate our patients today and every day!

Address

Catonsville, MD
21228

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 4:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Telephone

+14104026860

Alerts

Be the first to know and let us send you an email when Treatment Research Program - Maryland Psychiatric Research Center - MPRC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Treatment Research Program - Maryland Psychiatric Research Center - MPRC:

Share

Treatment Research Program - MPRC

The Treatment Research Program has been dedicated to the study and treatment of people with schizophrenia since 1989. The Program incorporates a diverse range of treatment relevant research and provides numerous opportunities including clinical trials of new medications and strategies to help move people with schizophrenia on the path to recovery.